biosimilar

Biocon Biologics' study identifies six policy recommendations to improve access to biosimilars in LMICs, addressing healthcare…

Bkemv is the first interchangeable biosimilar to Soliris to treat certain rare diseases

Insuquick is a “Make in India” product and is available in all metros, and tier I/II cities

Over 10 emerging markets along with Japan, Australia and New Zealand have transitioned in this final phase of the integration of…

Insuquick will be available in cartridges, vials, and prefilled disposable pens

herapeutic equivalence and safety confirmed between DMB-3115 and Stelara in global phase III

This Phase I study used an intravenous (IV) formulation to evaluate the pharmacokinetic equivalence, safety and immunogenicity of…

Abevmy 100 and 400 mg is approved for the treatment of metastatic colorectal carcinoma, metastatic breast cancer, non small-cell…

To complete the application, the agency noted that an inspection of the manufacturing facility is required as a part of the…

By the end of March 2020, Semglee was approved in 60 countries and launched in several countries including the EU, Australia and…